[10] reported subtype‐specific expression of GRHL3 with lower levels in triple‐negative breast cancer, and persistent GRHL3 expression was generally associated with longer overall survival of patients with lymph node metastases. Here, GRHL3 is linked to metastatic malignant neoplasm in the lymph nodes.